Skip to main content

Table 7 Side Effects.

From: Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

Study (Duration of Follow up) A. Bonifati, 2000 (12 months) B. Angelini, 1994 (12 months) F. Angelini, 1998 (12 months) G. Angelini, 1995 (unclear) N. Brooke, 1996 (12 months)
Weight Gain
Mean weight increase as a percentage of initial weight DFZ: 9% Pred: 21.3 % p < 0.05 Not significant. No numeric values given. Reported as minimal. No numeric values given. Not significantly different from the placebo. No numeric values given. DFZ low: 16.8% DFZ high: 18.3% Pred: 26.7% p < 0.01
Others
Fractures or osteoporosis N = 1 (DFZ) N = 1 (DFZ) Reported as minimal. No numeric values. - -
Hirsutism - N = 3 (total) - - -
Cushingoid - N = 2 (total) - - -
Increased Appetite - N = 4 (total) - - -
Behavior Changes - N = 5 (total) - - -
Cataract N = 2 (DFZ) N = 1 (Prednisone) - Reported as minimal. No numeric values. - -
  1. A dash represents that this side effect was not reported.